In previous studies, we concluded that CT staging can be used as a decision-making marker for the extent of lymph node dissection [ 19].
For example, using the Iowa gambling task (IGT), which is an experimental tool to investigate risk-taking decision making, somatic markers, such as palpitation or diaphoresis, precede a person's behavioral switch from risky to cautious choices [9] [10].
Additional characteristics would expand its clinical usefulness: a marker informative for an individual patient would facilitate clinical decision making while a marker that reliably measures reversibility of the disease process could become a surrogate end point in drug development and preventative treatment.
More specifically, it aims to provide insights into markers' decision making and internal negotiating strategies, especially in cases where difficult decisions needed to be made.
Prior antibiotic exposure may represent an important marker for decision making, especially as new broad-spectrum antibiotics begin to enter the clinical setting.
To summarize a great deal of literature, it is not clear that either marker contributes to decision making regarding endocrine treatment in women with ER-positive breast cancer.
Finally, it would be necessary to conduct a randomized trial to determine if the use of this marker for therapeutic decision making may increase disease-free survival in locally advanced HNSCC patients.
Uncovering these combinatorial survival effects will provide new markers for clinical decision making and personalized treatment of cancer patients [ 5].
However, although clinical parameters are validated predictors for OS, most prognostic profiles do not provide a decision making algorithm combining both the molecular markers and the clinicopathologic features (sex, age, stage, etc). of each patient.
The data could therefore be a marker for impairment in decision making following chronic cocaine use.
An ideal marker of sepsis should be beneficial when employed in medical decision making.
